Durysta
Payments companies reported to CMS as associated with Durysta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Durysta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Durysta
These are the largest totals companies reported as associated with Durysta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Courtney Bovee | Tampa, FL | Ophthalmology | $419,186.59 |
| Peter Chang | Houston, TX | Ophthalmology | $261,600.60 |
| Jonathan Grady | Lake Jackson, TX | Ophthalmology | $190,170.38 |
| Jason Bacharach | Petaluma, CA | Glaucoma Specialist | $176,243.04 |
| John Stephens | Cape Coral, FL | Ophthalmology | $112,435.84 |
| Eric Mann | Dover, NJ | Ophthalmology | $100,652.06 |
| Nora Cothran | Largo, FL | Optometrist | $100,190.54 |
| Nathan Radcliffe | New York, NY | Ophthalmology | $96,377.15 |
| Robert Noecker | Pittsburgh, PA | $88,899.13 | |
| Savak Teymoorian | Laguna Hills, CA | Ophthalmology | $88,702.40 |
Prescribed Durysta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.